In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 413-420

  Jaworski, Sławomir ^a   Sawosz, Ewa ^a   Grodzik, Marta ^a   Winnicka, Anna ^a   Prasek, Marta ^a   Wierzbicki, Mateusz ^a   Chwalibog, André ^b  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Apoptosis; Glioma; Toxicity

Indexed keywords

GRAPHENE; GRAPHENE PLATELET; LACTATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL LINE; CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; OPTICAL DENSITY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

APOPTOSIS; GLIOMA; TOXICITY;

ANALYSIS OF VARIANCE; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SHAPE; CELL SURVIVAL; GLIOBLASTOMA; GRAPHITE; HUMANS; NANOPARTICLES;

EID: 84873043136     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S39456     Document Type: Article

References (25)

1. Westermark B. Glioblastoma - a moving target. Ups J Med Sci. 2012; 117(2):251-256.
2. Cloughesy T. The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma. Semin Oncol. 2011;38 Suppl 4: S11-S20.
3. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004;53(3):153-159.
4. Tabunoki H, Saito N, Suwanborirux K, Charupant K, Satoh J. Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids. Cancer Cell Int. 2011;12(1):14.
5. An YL, Nie F, Wang ZY, Zhang DS. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells. Int J Nanomedicine. 2011;6:3187-3194.
6. Grodzik M, Sawosz E, Wierzbicki M, et al. Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo. Int J Nanomedicine. 2011;6:3041-3048.
7. Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009;61(6):457-466.
8. Geim AK, Novoselov KS. The rise of graphene. Nat Mater. 2007;6(3): 183-191.
9. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 2013;42(2):530-547.
10. Strakova N, Ehrmann J, Dzubak P, Bouchal J, Kolar Z. The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines. J Pharmacol Exp Ther. 2004; 309(3):1239-1247.
11. Zhang LM, Xia JG, Zhao QW, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010;6(4):537-544.
12. Chang Y, Yang ST, Liu JH, et al. In vitro toxicity evaluation of graphene oxide on A549cells. Toxicology Lett. 2011;200(3):201-210.
13. Chwalibog A, Sawosz E, Hotowy A, et al. Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int J Nanomedicine. 2010;5:1085-1094.
14. Wang K, Ruan J, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett. 2011;6:8.
15. Agarwal S, Zhou X, Ye F, et al. Interfacing live cells with nanocarbon substrates. Langmuir. 2010;26(4):2244-2247.
16. Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 2008;130(33): 10876-10877.
17. Liu JH, Anilkumar P, Cao L, et al. Cytotoxity evaluations of fluorescent carbon nanoparticles. Nano Life. 2010;1(2):153-161.
18. Lv M, Zhang Y, Liang L, et al. Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale. 2012;4(13):3861-3866.
19. Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials. 2011;32(4): 1121-1129.
20. Schinwald A, Murphy FA, Jones A, MacNee W, Donaldson K. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano. 2012;6(1):736-746.
21. Duch MC, Budinger GR, Liang YT, et al. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of grapheme in the lung. Nano Lett. 2011;11(12):5201-5207.
22. Li Y, Liu Y, Fu Y, et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials. 2012;33(2):402-411.
23. Guo L, Von Dem Bussche A, Buechner M, Yan A, Kane AB, Hurt RH. Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. Small. 2008;4(6):721-727.
24. Stockmann-Juvala H, Naarala J, Loikkanen J, Vähäkangas K, Savolainen K. Fumonisin B1-induced apoptosis in neuroblastoma, glioblastoma and hypothalamic cell lines. Toxicology. 2006;225(2-3):234-241.
25. Zhu M, Weiss RS. Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1in primary cultured cells. Mol Biol Cell. 2007;18(3):1044-1055.